546 related articles for article (PubMed ID: 25633209)
1. Soft matter assemblies as nanomedicine platforms for cancer chemotherapy: a journey from market products towards novel approaches.
Jäger E; Giacomelli FC
Curr Top Med Chem; 2015; 15(4):328-44. PubMed ID: 25633209
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Tumor-targeted nanomedicines for cancer theranostics.
Arranja AG; Pathak V; Lammers T; Shi Y
Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology platforms and physiological challenges for cancer therapeutics.
Kim KY
Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
[TBL] [Abstract][Full Text] [Related]
6. Block Copolymer Micelles in Nanomedicine Applications.
Cabral H; Miyata K; Osada K; Kataoka K
Chem Rev; 2018 Jul; 118(14):6844-6892. PubMed ID: 29957926
[TBL] [Abstract][Full Text] [Related]
7. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
Bharali DJ; Mousa SA
Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
[TBL] [Abstract][Full Text] [Related]
8. Advances in nanomedicine towards clinical application in oncology and immunology.
Herreros E; Morales S; Cortés C; Cabaña M; Peñaloza JP; Jara L; Geraldo D; Otero C; Fernández-Ramires R
Curr Pharm Biotechnol; 2014; 15(9):864-79. PubMed ID: 25213311
[TBL] [Abstract][Full Text] [Related]
9. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
10. Designing polymer conjugates as lysosomotropic nanomedicines.
Duncan R
Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine: is it lost in translation?
Greish K; Mathur A; Bakhiet M; Taurin S
Ther Deliv; 2018 Mar; 9(4):269-285. PubMed ID: 29495928
[TBL] [Abstract][Full Text] [Related]
12. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities.
Farjadian F; Ghasemi A; Gohari O; Roointan A; Karimi M; Hamblin MR
Nanomedicine (Lond); 2019 Jan; 14(1):93-126. PubMed ID: 30451076
[TBL] [Abstract][Full Text] [Related]
13. Microfluidic and lab-on-a-chip preparation routes for organic nanoparticles and vesicular systems for nanomedicine applications.
Capretto L; Carugo D; Mazzitelli S; Nastruzzi C; Zhang X
Adv Drug Deliv Rev; 2013 Nov; 65(11-12):1496-532. PubMed ID: 23933616
[TBL] [Abstract][Full Text] [Related]
14. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
15. Application of Nanotechnology in Cancer Diagnosis and Therapy - A Mini-Review.
Jin C; Wang K; Oppong-Gyebi A; Hu J
Int J Med Sci; 2020; 17(18):2964-2973. PubMed ID: 33173417
[TBL] [Abstract][Full Text] [Related]
16. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
[TBL] [Abstract][Full Text] [Related]
17. Nanotechnology-based intelligent drug design for cancer metastasis treatment.
Gao Y; Xie J; Chen H; Gu S; Zhao R; Shao J; Jia L
Biotechnol Adv; 2014; 32(4):761-77. PubMed ID: 24211475
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicine in cancer therapy: innovative trends and prospects.
Blanco E; Hsiao A; Mann AP; Landry MG; Meric-Bernstam F; Ferrari M
Cancer Sci; 2011 Jul; 102(7):1247-52. PubMed ID: 21447010
[TBL] [Abstract][Full Text] [Related]
19. Nanoscale drug delivery for targeted chemotherapy.
Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine for Treatment of Lung Cancer.
Hussain S
Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
